Forskning ved Københavns Universitet - Københavns Universitet

Forside

STAT5 induces miR-21 expression in cutaneous T cell lymphoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Lise M. Lindahl
  • Simon Fredholm
  • Claudine Vanessa Joseph
  • Boye Schnack Nielsen
  • Lars Jønson
  • Edda Blümel
  • Nina Sibbesen
  • Tengpeng Hu
  • Ditte Jæhger
  • Jenny L. Persson
  • Nigel Mongan
  • Mariusz A. Wasik
  • Ivan V. Litvinov
  • Denis Sasseville
  • Sergei B. Koralov
  • Elisabeth Ralfkiaer
  • Lars Iversen

In cutaneous T cell lymphomas (CTCL), miR-21 is aberrantly expressed in skin and peripheral blood and displays anti-apoptotic properties in malignant T cells. It is, however, unclear exactly which cells express miR-21 and what mechanisms regulate miR-21. Here, we demonstrate miR-21 expression in situ in both malignant and reactive lymphocytes as well as stromal cells. qRT-PCR analysis of 47 patients with mycosis fungoides (MF) and Sezary Syndrome (SS) confirmed an increased miR- 21 expression that correlated with progressive disease. In cultured malignant T cells miR-21 expression was inhibited by Tofacitinib (CP-690550), a clinical-grade JAK3 inhibitor. Chromatin immunoprecipitation (ChIP) analysis showed direct binding of STAT5 to the miR-21 promoter. Cytokine starvation ex vivo triggered a decrease in miR-21 expression, whereas IL-2 induced an increased miR-21 expression in primary SS T cells and cultured cytokine-dependent SS cells (SeAx). siRNA-mediated depletion of STAT5 inhibited constitutive- and IL-2- induced miR-21 expression in cytokine- independent and dependent T cell lines, respectively. IL-15 and IL-2 were more potent than IL-21 in inducing miR-21 expression in the cytokine-dependent T cells. In conclusion, we provide first evidence that miR-21 is expressed in situ in CTCL skin lesions, induced by IL-2 and IL-15 cytokines, and is regulated by STAT5 in malignant T cells. Thus, our data provide novel evidence for a pathological role of IL-2Rg cytokines in promoting expression of the oncogenic miR-21 in CTCL.

OriginalsprogEngelsk
TidsskriftOncoTarget
Vol/bind7
Udgave nummer29
Sider (fra-til)45730-45744
Antal sider15
ISSN1949-2553
DOI
StatusUdgivet - 2016

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 168874893